Cargando…
Gamma-Glutamyl Transferase as a Diagnostic Marker of Metabolic Syndrome
Introduction The metabolic syndrome consists of metabolic abnormalities that increase the risk of cardiovascular disease (CVD) and cerebrovascular disease. Metabolic syndrome (MetS) is a growing problem worldwide, and substantial efforts have been made in the last years to identify early, minimally...
Autores principales: | Naidu, Bobbili Tarun Kesava, Santosh Raju, Kakarlapudi, BhaskaraRao, Janapareddi V, Sunil Kumar, Nallapati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375041/ https://www.ncbi.nlm.nih.gov/pubmed/37519590 http://dx.doi.org/10.7759/cureus.41060 |
Ejemplares similares
-
A Study of Hypomagnesemia in Patients Admitted to the ICU
por: Santosh Raju, Kakarlapudi, et al.
Publicado: (2023) -
Gamma-glutamyl transferase: risk and prognosis of cancer
por: Fentiman, I S
Publicado: (2012) -
Increased concentration of serum gamma-glutamyl transferase in ischemic stroke patients
por: Kalirawna, Teja Ram, et al.
Publicado: (2021) -
Gamma-Glutamyl Transferase Levels in Patients with Acute Ischemic Stroke
por: Gurbuzer, Nurbanu, et al.
Publicado: (2014) -
Association of Serum Gamma-Glutamyl Transferase and Ferritin with the Metabolic Syndrome
por: Wei, Dong, et al.
Publicado: (2015)